Cholangiocarcinoma landscape in Europe: diagnostic, prognostic and therapeutic insights from the ENSCCA Registry

189 p.El colangiocarcinoma (CCA) es un cáncer biliar raro y heterogéneo, con una incidencia y mortalidad creciente. Este estudio investiga el curso natural de CCA y sus subtipos en una cohorte paneuropea. El estudio incluyó 2.234 pacientes (hombre:mujer 1,29). El iCCA (n=1.243) se asoció con sobrepeso/obesidad (58,5%) y hepatopatías crónicas, incluyendo la cirrosis (12,6%) y/o hepatitis virales (10,4%); el pCCA (n=592) con la colangitis esclerosante primaria (8,8%); y el dCCA (n=399) con cálculos biliares (10,3%). Al diagnóstico, el 42,2 % de los pacientes tenían enfermedad local, el 29,4 % enfermedad localmente avanzada (LAD) y el 28,4 % enfermedad metastásica (MD). El CEA y el CA19-9 mostraron una baja sensibilidad diagnóstica (69,1% y 40,9% por debajo del punto de corte, respectivamente), pero su elevación se asoció con un mayor riesgo de presentar LAD [OR 2,16; IC95% 1,43-3,27] o MD [OR 5,88; IC95% 3,69-9,25]. Los pacientes sometidos a resección tumoral (50,3 %) mostraron el mejor pronóstico, en particular aquellos con margen de resección negativo (R0) [supervivencia global (SG) = 45,1 meses]; sin embargo, la afectación de los márgenes (R1) [HR 1,92; IC95% 1,53-2,41; SG = 24,7 meses] y la invasión de ganglios linfáticos [HR 2,13; IC95% 1,55-2,94; SG = 23,3 meses] comprometieron la supervivencia. Entre los pacientes con enfermedad irresecable (49,6%), la SG fue de 10,6 meses para los que recibieron terapias anti-cancer, principalmente quimioterapia (26,2%). Los pacientes que recibieron la mejor atención de apoyo (20,6%) tuvieron una SG de 4,0 meses, siendo el iCCA el que peor pronóstico mostraba. El estado funcional [HR 1.52; IC95% 1.01-2.31], la presencia de metástasis [HR 4.03; IC95% 1.82-8.92] y el CA19-9 [HR 2.79; IC95% 1.46-5.33] fueron factores de pronóstico independientes

Batch and Continuous Chromate and Zinc Sorption from Electroplating Effluents Using Biogenic Iron Precipitates

Nanoparticles of iron precipitates produced by a microbial consortium are a suitable adsorbent for metal removal from electroplating industry wastewaters. Biogenic iron precipitates were utilized as adsorbents for chromate and zinc in batch conditions. Furthermore, the iron precipitates were embedded in alginate beads for metal removal in fixed-bed columns, and their performance was evaluated in a continuous system by varying different operational parameters such as flow rate, bed height, and feeding system (down- and up-flows). The influence of different adsorption variables in the saturation time, the amount of adsorbed potentially toxic metals, and the column performance was investigated, and the shape of the breakthrough curves was analyzed. The optimal column performance was achieved by increasing bed height and by decreasing feed flow rate and inlet metal concentration. The up-flow system significantly improved the metal uptake, avoiding the preferential flow channels.Depto. de Ingeniería Química y de MaterialesFac. de Ciencias QuímicasTRUEMinisterio de Economía y Competitividadpu

Compliance Surveillance of the Tobacco Control Legislation in a Spanish Region and Characterization of Passive Exposure to Tobacco Smoke and E-Cig in Children in Outdoor Spaces

Children; Smoking signage; Tobacco control legislationNiños; Señalización de fumar; Legislación de control del tabacoNens; Senyalització de fumar; Legislació de control del tabac(1) Background: Exposure to environmental tobacco smoke has decreased in recent years in Spain, due to the implementation of tobacco control policies. However, there is no regulation that protects against second-hand smoke (SHS) in outdoor environments. Our goal is to describe the smoking prohibition signage in public spaces and to characterize tobacco consumption in outdoor environments describing the SHS exposure in children. (2) Methods: A cross-sectional study using direct observation was carried out with a convenience sample (n = 179) that included hospitality venues with terraces, schools and healthcare facilities in the municipality of Sant Cugat del Vallès (Barcelona, Spain). The observations were made without notifying the owners by one single field researcher between April and June 2018. The variables were evaluated by signage and signs of tobacco consumption (ashtrays, cigarette butts and presence of smokers). (3) Results: Smoke-free zone signage outside public spaces was present in 30.7% of all venues, with only 50.9% correctness. When analysing terraces of hospitality venues, in 35.8% of them there were children present with 66.7% of tobacco consumption. (4) Conclusions: Our results show a low prevalence of antismoking signage, without an impact on tobacco consumption regardless of the presence of children

EI diseño de experimentos como herramienta para la mejora de los procesos. Aplicación de la metodología al caso de una catapulta

Con este artículo se pretende resaltar la planificación de la investigación como parte importante en el desarrollo de un diseño de experimentos; para ello se muestra una metodología para la aplicación práctica de esta clase de diseños. El procedimiento recomendable para llevarlo a cabo se presenta de forma teórica y, paralelamente, es aplicado al caso práctico de mejorar el alcance del tiro de una catapulta

Enfermedad meningocócica en España. Análisis de la temporada 2016-2017

[ES] La enfermedad meningocócica es de declaración obligatoria en España. Los casos se notifican de manera individualizada con periodicidad semanal, incluyendo información epidemiológica y microbiológica a través de la Red Nacional de Vigilancia Epidemiológica (RENAVE). La presentación de esta enfermedad en la población española ha sufrido cambios muy importantes. El uso de la vacuna frente al serogrupo C ha causado un gran descenso de la incidencia por este serogrupo. Además en la última década también han disminuido los casos por serogrupo B. En la temporada 2016-2017 se notificaron 321 casos, de los que se confirmaron 270 y la incidencia fue de 0,58 por 100.000 habitantes. Se presenta el análisis de los resultados generales de la vigilancia epidemiológica de la enfermedad meningocócica para la temporada 2016-2017 en España y su comparación con las previas. [EN] Meningococcal disease is notifiable in Spain. The cases were notified individually on a weekly basis, including epidemiological and microbiological information through the National Network of Epidemiological Surveillance (RENAVE). The incidence of this disease in the Spanish population has undergone very important changes. Vaccination against serogroup C has caused a large decrease in the incidence of this serogroup. In addition, in the last decade cases caused by serogroup B have also decreased. In the 2016-2017 season, 321 cases were notified, of which 270 were confirmed and the incidence was 0.58 per 100,000 inhabitants. We analyzed the results of the epidemiological surveillance of meningococcal disease for the 2016-2017 season in Spain and its comparison with the previous ones

Trends in urinary tract infection hospitalization in older adults in Spain from 2000-2015

Objective: To analyze trends in urinary tract infection hospitalization (cystitis, pyelonephritis, prostatitis and non-specified UTI) among patients over 65 years in Spain from 2000-2015. Methods: We conducted a retrospective observational study using the Spanish Hospitalization Minimum Data Set (CMBD), with codifications by the International Classification of Diseases (ICD-9). We collected data on sex, age, type of discharge, main diagnosis, comorbid diagnosis, length of stay, and global cost. All the hospitalizations were grouped by age into three categories: 65-74 years old, 75-84 years old, and 85 years old and above. In the descriptive statistical analysis, crude rates were defined as hospitalizations per 1,000 inhabitants aged ≥65. To identify trends over time, we performed a Joinpoint regression. Results: From 2000-2015, we found 387,010 hospitalizations coded as UTIs (54,427 pyelonephritis, 15,869 prostatitis, 2643 cystitis and 314,071 non-specified UTI). The crude rate of hospitalization for UTIs between 2000 and 2015 ranged from 2.09 in 2000 to 4.33 in 2015 Rates of hospitalization were higher in men than in women, except with pyelonephritis. By age group, higher rates were observed in patients aged 85 years or older, barring prostatitis-related hospitalizations. Joinpoint analyses showed an average annual percentage increase (AAPC) in incidence rates of 4.9% (95% CI 3.2;6.1) in UTI hospitalizations. We observed two joinpoints, in 2010 and 2013, that found trends of 5.5% between 2000 and 2010 (95% CI 4.7;6.4), 1.5% between 2010 and 2013 (95% CI -6.0;9.6) and 6.8% between 2013 and 2015 (95% CI -0.3;14.4). Conclusions: The urinary infection-related hospitalization rate in Spain doubled during the period 2000-2015. The highest hospitalization rates occurred in men, in the ≥85 years old age group, and in non-specified UTIs. There were increases in all types of urinary tract infection, with non-specified UTIs having the greatest growth. Understanding these changing trends can be useful for health planning.This study has been funded by Instituto de Salud Carlos III through the project “PI19/01700”, as part of the Plan Estatal de I+D+I 2017-2020 co-funded by European Regional Development Fund (ERDF) “A way of shaping Europe”. In addition, the principal investigator JRS received support to increase his research activities and to publish this manuscript from the 2020 funding program of the Fundación de Investigación e Innovación Biosanitaria en Atención Primaria (FIIBAP), Community of Madrid.S

Tailoring the physical properties of hybrid magnetic quinuclidine-based plastic compounds via weak interactions

Herein we explore the opportunities arising from combining bicyclic amine cations with halometallate anions to build organic–inorganic hybrid materials. We will use the crystal engineering approach in these materials, focusing on the tuning of the organic cation, which is mainly responsible for obtaining both new plastic states at high temperature and electrical behaviour below the plastic temperature. Precisely, this work explores the influence of the ketonization of the bicyclic quinuclidine molecule (C7H13N)+, which, combined with the tetrachloroferrate(1-) anion, gives the compound (3-oxoquinuclidinium)[FeCl4]. Interestingly, crystallization in the presence of humidity is enough to obtain an isostructural hydrate phase of formula (3-oxoquinuclidinium)[FeCl4]·H2O. Although the organic–inorganic layered structure is the same in both compounds, the three-dimensional magnetic ordering disappears after the intercalation of crystallization water molecules. A heat treatment above 400 K allows the removal of water obtaining the non-hydrate phase. Finally, the temperature evolution of the electric and magnetic behaviour will be compared with other previously reported hybrid organic–inorganic materials built with tetrachloroferrate ions and quinuclidinium-based cations.Financial support from Universidad de Cantabria (Proyecto Puente convocatoria 2018 funded by SODERCAN_FEDER), Universidad del País Vasco/Euskal Herriko Unibertsitatea (GIU17/50 and PPG17/37) and Ministerio de Economia y Competividad (MAT2017-89239-C2-(1,2)-P, MAT2017-83631-C3-3-R and MAT2017-86453-R) is acknowledged. The authors gratefully acknowledge technical and human support provided by SGIKer (UPV/EHU, MINECO, GV/EJ, ERDF, and ESF). The paper is (partly) based on the results of experiments carried out at the ALBA Synchrotron Light Source in Barcelona and Institute Laue-Langevin (ILL) in Grenoble (Proposals 5-31-2673 and 5-12-358)

Reporte del monitoreo ambiental en el marco de la supervisión regular, llevado a cabo el 15 de abril de 2014, en la empresa Curtiembre La Pisqueña S.A.

Presenta el reporte del monitoreo ambiental realizado en el marco de la Supervisión Regular, de la empresa Curtiembre La Pisqueña S.A., llevado a cabo el 15 de abril de 2014, en el distrito Pisco, provincia Pisco, departamento lca. Esta ficha no incluye los resultados analíticos de los monitoreos ambientales. Esta ficha no incluye los resultados analíticos de los monitoreos ambientales

Effect of mTORC1/mTORC2 inhibition on T cell function: potential role in graft-versus-host disease control

Producción CientíficaThe mechanistic target of rapamycin (mTOR) pathway is crucial for the activation and function of T cells, which play an essential role in the development of graft-versus-host disease (GvHD). Despite its partial ability to block mTOR pathway, the mTORC1 inhibitor rapamycin has shown encouraging results in the control of GvHD. Therefore, we considered that simultaneous targeting of both mTORC1 and mTORC2 complexes could exert a more potent inhibition of T cell activation and, thus, could have utility in GvHD control. To assess this assumption, we have used the dual mTORC1/mTORC2 inhibitors CC214-1 and CC214-2. In vitro studies confirmed the superior ability of CC214-1 versus rapamycin to block mTORC1 and mTORC2 activity and to reduce T cell proliferation. Both drugs induced a similar decrease in Th1/Th2 cytokine secretion, but CC214-1 was more efficient in inhibiting na€ıve T cell activation and the expression of Tcell activation markers. In addition, CC214-1 induced specific tolerance against alloantigens, while preserving anti-cytomegalovirus response. Finally, in a mouse model of GvHD, the administration of CC214-2 significantly improved mice survival and decreased GvHD-induced damages. In conclusion, the current study shows, for the first time, the immunosuppressive ability of CC214-1 on T lymphocytes and illustrates the role of CC214-2 in the allogeneic transplantation setting as a possible GvHD prophylaxis agent.Gerencia Regional de Salud de Castilla y León (Proyecto GRS 726/A13

Early onset of azithromycin to prevent clad in lung transplantation: promising results of a retrospective single centre experience

Introduction: Azithromycin (AZI) may be an effective immune modulator in lung transplant (LT) recipients, and can decrease chronic lung allograft dysfunction (CLAD) rates, the leading cause of mortality after the first year post-LT. The aim of the study is to assess the effect of AZI initiation and its timing on the incidence and severity of CLAD in LT recipients. Methods: Single-center retrospective study, including LT recipients from 01/01/2011 to 30/06/2020. Four groups were established: those who started AZI at the 3rd week post-LT (group A), those who received AZI later than the 3rd week post-LT and had preserved FEV1 (B), those who did not receive AZI (C) and those who started AZI due to a decline in FEV1 (D). The dosage of AZI prescribed was 250 mg three times per week. CLAD was defined and graduated according to the 2019 ISHLT criteria. Results: We included 358 LT recipients: 139 (38.83%) were in group A, 94 (26.25%) in group B, 91 (25.42%) in group C, and 34 (9.50%) in group D. Group A experienced the lowest CLAD incidence and severity at 1 (p = 0.01), 3 (p < 0.001), and 5 years post-LT, followed by Group B. Groups C and D experienced a higher incidence and severity of CLAD (p = 0.015). Initiation of AZI prior to FEV1 decline (groups A and B) proved to be protective against CLAD after adjusting for differences between the treatment groups. Conclusions: Early initiation of AZI in LT recipients could have a role in decreasing the incidence and severity of CLAD. In addition, as long as FEV1 is preserved, initiating AZI at any time could also be useful to prevent the incidence of CLAD and reduce its severity. This article is protected by copyright. All rights reserved.Funding Sources: This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors